You may have heard about Delic Corp in the context of ketamine therapy or psilocybin research. You will soon understand why they matter. Delic Corp combines clinics, labs, events and media. You get access to care built on science and community.

What Delic Corp Actually Does

Delic Corp began as a media and event company focused on psychedelics. Over time, they acquired media brands like Reality Sandwich and podcasts like Delic Radio. They host the Meet Delic conference. They also acquired Complex Biotech Discovery Ventures (CBDV), now Delic Labs—a licensed research lab in Canada focused on psilocybin vaporization and multiple compounds like MDMA, LSD, DMT, mescaline, and more (GlobeNewswire). They also acquired Ketamine Infusion Centers, creating one of the largest clinic networks in the U.S. (Stock Titan). Through these strategic moves, Delic Corp Stock has positioned itself as a leader in psychedelic wellness, combining media, science, and clinical care under one umbrella.

How It Helps You

Delic Corp offers real care and real research. Here is what they give you:

Medical supervised ketamine therapy via clinic network.

Treatment plans guided by professionals.

Research from Delic Labs that improves delivery methods.

Community learning through Meet Delic events and media content.

You’re not just getting treatment. You benefit from innovations, safety data, and shared knowledge. Delic’s ecosystem connects you to care built on evidence and progress.

What Makes Them Unique

Clinics That Scale

Delic owns one of the largest profitable ketamine clinic chains in the U.S. . That gives you access in multiple states with consistent protocols.

Lab Powerhouse

Delic Labs leads Canadian psilocybin research. Since April 2022 they hold Health Canada research exemptions for compounds including psilocybin MDMA LSD and mescaline (Benzinga). They build IP around vaporization and analytical testing.

Education & Media

Reality Sandwich helps you learn. Delic Radio keeps you informed. Meet Delic events gather experts and patients to share stories and science (Newsfile, GlobeNewswire).

Integrated Model

From research to treatment to community, everything feeds into a cohesive platform. That keeps care evolving. One breakthrough in the lab helps you at the clinic.

Key Recent Milestones

• April 2022: Delic Labs obtained Health Canada Section 56 Research Exemption for psilocybin and more (Benzinga).
  
• 2021: They acquired CBDV to scale biotech capacity and IP development in psychedelics and cannabis (Newsfile).
  
• 2021–2023: Acquisition of Ketamine Infusion Centers expanded their U.S. clinic presence and operations (Stock Titan).
  
• Morgan leadership changes: In March 2023 Delic suspended some clinic operations and reevaluated strategy while maintaining core media and lab operations (stockwatch.com).
  

What You Experience

If you visit a Delic clinic you get:

Mental health intake and treatment planning.

Supervised ketamine sessions.

Post‑session integration support.

Access to new delivery formats as research evolves.

Delic Labs continues to refine dosing and safety through analytics. You benefit from better methods and more consistent results.

How Research Impacts Your Journey

Delic Labs holds rare Canadian licenses to test compounds beyond psilocybin. They craft delivery tools like vapor systems. They work with partners like GT Research for genetic analysis and quality control. That leads to safer, more precise care.

Their research drives advances in dosing, purity and therapeutic methods that clinics can adopt directly.

Media and Community Engagement

Reality Sandwich delivers articles grounded in real science and lived experience.
Delic Radio offers interviews with scientists and mental health professionals.
Meet Delic events bring you face to face with thought leaders patients and innovators. Speakers have included people like Lamar Odom sharing recovery stories

This content keeps you informed before and after treatment.

Who Benefits

You should explore Delic if you:

Experience treatment-resistant depression, PTSD anxiety or chronic pain.

Seek supervised psychedelic therapy in a controlled setting.

I want to join a community focused on inquiry and healing.

Value a framework where research informs care.

Delic gives you more than therapy. You get access to evolving methods backed by science and community support.

FAQs

What disorders does Delic Corp treat?
They focus on mental health issues like depression anxiety, PTSD chronic pain and treatment-resistant cases via ketamine-assisted therapy.

Which psychedelics do they use?
Primarily ketamine in U.S. clinics. Delic Labs researches psilocybin vapor, MDMA LSD DMT and mescaline in Canada.

Where are clinics located?
They span multiple U.S. states. You can check their site for current locations.

Is research licensed?
Delic Labs holds Health Canada Section 56 exemptions for research on several compounds. They intend to acquire a Dealer’s License to commercialize findings 

Are treatments FDA approved?
Ketamine is FDA‑approved for anesthesia and used off‑label for mental health. Psilocybin and MDMA remain investigational in most jurisdictions.

Will insurance cover treatment?
Coverage varies by plan and state. Each clinic can help clarify cost reimbursement policies.

Summary

Delic Corp stands at the crossroads of care innovation content and community. They bring ketamine clinics to patients. They run labs that test and invent new delivery methods. They produce media that educates. They host events that connect.You get care shaped by ongoing research. You get support from a broader community. You get access in safe settings run by professionals.If you want mental health options beyond standard pharmaceuticals, Delic Corp puts a clear path in front of you. Visit their website. Look at clinics near you. Explore media content. Join a Meet Delic event. You get to lead your own journey to healing.